Corner Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Corner Therapeutics?

Corner Therapeutics has 4 investors including Sandia Holdings And Ziff Capital Partners.

Q: How much funding has Corner Therapeutics raised to date?

Corner Therapeutics has raised obfuscated.

Overview

Corner Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Corner Therapeutics

CB Rank

37730

Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.

Founded

obfuscation

Private

Series A

Watertown, Massachusetts, United States

11-50

cornertx.com

Biotechnology

Health Care

Life Science

Funding Rounds

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Andrew Bellinger: Co-Founder
Past Role: Verve Therapeutics, Chief Scientific Officer / Chief Medical Officer
Jeff Karp: Co-Founder

Details

Legal Name

Corner Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Andrew Bellinger, Jeff Karp, Jonathan Kagan

Phone Number

1-617-701-7014

Contact Email

contact@cornertx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Dendritic Cell Hyperactivation Platform

A platform that enhances dendritic cells to induce robust and durable T cell responses, providing long-term immunity against cancers and infectious diseases.

Catalytic Adjuvant Platform

A vaccine strategy that uses a catalytic adjuvant encoded by mRNA to generate both CD8+ T cell and B cell responses for immunotherapies.

Research & Development

Corner Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A
obfuscated obfuscation	Series A - Corner Therapeutics	3	obfuscated obfuscation	Ziff Capital Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sandia Holdings	—	Series A - Corner Therapeutics	—
Sandia Holdings	—	Series A - Corner Therapeutics	—
Sandia Holdings	—	Series A - Corner Therapeutics	—
Sandia Holdings	—	Series A - Corner Therapeutics	—
Sandia Holdings	—	Series A - Corner Therapeutics	—